Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Dive

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
Cancer Discovery|October 14, 2025
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β AxisCharles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, et al.
Nature Cancer|February 5, 2022
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneityKathryn L Simpson, Ruth Stoney, Kristopher K Frese, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Nature Cancer|August 8, 2022
cfDNA methylome profiling for detection and subtyping of small cell lung cancersFrancesca Chemi, Simon P Pearce, Alexandra Clipson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axisCharles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I TrialCostanza Paoletti, Gaia Schiavon, Emily M Dolce, et al.
Nature Medicine|June 2, 2014
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancerCassandra L Hodgkinson, Christopher J Morrow, Yaoyong Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Nature Communications|November 9, 2018
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancerGordon C Jayson, Cong Zhou, Alison Backen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2023
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic MimicrySarah M Pearsall, Stuart C Williamson, Sam Humphrey, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Cancer Discovery|October 14, 2025
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β AxisCharles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, et al.
Nature Cancer|February 5, 2022
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneityKathryn L Simpson, Ruth Stoney, Kristopher K Frese, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Nature Cancer|August 8, 2022
cfDNA methylome profiling for detection and subtyping of small cell lung cancersFrancesca Chemi, Simon P Pearce, Alexandra Clipson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axisCharles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I TrialCostanza Paoletti, Gaia Schiavon, Emily M Dolce, et al.
Nature Medicine|June 2, 2014
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancerCassandra L Hodgkinson, Christopher J Morrow, Yaoyong Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Nature Communications|November 9, 2018
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancerGordon C Jayson, Cong Zhou, Alison Backen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2023
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic MimicrySarah M Pearsall, Stuart C Williamson, Sam Humphrey, et al.
Pageof 21